• Foods from the legume family include beans, peas, lentils, peanuts, and soybeans. (More information)
  • Legumes are excellent sources of protein, low-glycemic index carbohydrates, essential micronutrients, and fiber.
  • Substituting legumes for foods that are high in saturated fats or refined carbohydrates is likely to lower the risk of cardiovascular disease and type 2 diabetes mellitus. (More information)
  • Although legumes are rich in a number of compounds that could potentially reduce the risk of certain cancers, the results of epidemiological studies are too inconsistent to draw any firm conclusions regarding legume intake and cancer risk in general. (More information)
  • The 2005 Dietary Guidelines for Americans recommend a weekly intake of six servings (3 cups) of legumes for people who consume 2,000 kcal/day. (More information)


Legumes are plants with seed pods that split into two halves. Edible seeds from plants in the legume family include beans, peas, lentils, soybeans, and peanuts. Since peanuts are nutritionally similar to tree nuts, information on the health benefits of peanuts is presented in the article on nuts. Although legumes are an important part of traditional diets around the world, they are often neglected in typical Western diets. Legumes are inexpensive, nutrient-dense sources of protein that can be substituted for dietary animal protein (1). While sources of animal protein are often rich in saturated fats, the small quantities of fats in legumes are mostly unsaturated fats. Not only are legumes excellent sources of essential minerals, but they are also rich in dietary fiber and other phytochemicals that may affect health. Soybeans have attracted the most scientific interest, mainly because they are a unique source of phytoestrogens known as isoflavones (2). Although most other legumes lack isoflavones, they also represent unique packages of nutrients and phytochemicals that may work synergistically to reduce risk of chronic diseases.

Note: Research on the health effects of diets rich in legumes and soyfoods is summarized below. For a discussion of the potential health benefits and risks of soy isoflavones, see the article on Soy Isoflavones.

Disease Prevention

Type 2 diabetes mellitus

The glycemic index is a measure of the potential for carbohydrates in different foods to raise blood glucose levels. In general, consuming foods with high-glycemic index values causes blood glucose levels to rise more rapidly, which results in greater insulin secretion by the pancreas, than after consuming foods with low-glycemic index values. Chronically elevated blood glucose levels and excessive insulin secretion are thought to play important roles in the development of type 2 diabetes mellitus (DM) (3). Because legumes generally have low-glycemic index values, substituting legumes for high-glycemic index foods like white rice or potatoes lowers the glycemic load of one’s diet. Low-glycemic load diets have been associated with reduced risk of developing type 2 DM in several large prospective studies (4-7). Obesity is another important risk factor for type 2 DM. Numerous clinical trials have shown that the consumption of low-glycemic index foods delays the return of hunger, decreases subsequent food intake, and increases the sensation of fullness compared to high-glycemic index foods (8, 9). The results of several small, short-term trials (1-6 months) suggest that low-glycemic load diets result in significantly more weight or fat loss than high-glycemic load diets (10-13). Thus, diets rich in legumes may decrease the risk of type 2 diabetes by improving blood glucose control, decreasing insulin secretion, and delaying the return of hunger after a meal. For more information on glycemic index values and glycemic load, see the article on Glycemic Index and Glycemic Load. One study in elderly men and women reported that consumption of legumes was protective against the development of glucose intolerance (14). More recently, a prospective cohort study in 64,227 middle-aged Chinese women found that total legume consumption, which included soybeans, peanuts, and other legumes, was associated with a 38% lower risk of developing type 2 DM (15). Moreover, a prospective study that followed 10,449 diabetics for nine years found that legume intake was inversely associated with cardiovascular-related mortality and all-cause mortality, but not with cancer-related mortality (16).

Cardiovascular disease

Beans, peas, and lentils

One prospective cohort study that examined the effect of legume intake on cardiovascular disease risk followed men and women for 19 years and found those who ate dry beans, peas, or peanuts at least four times weekly had a risk of coronary heart disease (CHD) that was 21% lower than those who ate them less than once weekly (17). When compared to a typical Western diet, legume intake as part of a healthy dietary pattern that included higher intakes of vegetables, fruit, whole grains, fish, and poultry was associated with a risk of CHD that was 30% lower in men (18) and 24% lower in women (19). The results of controlled clinical trials suggest that increasing bean consumption improves serum lipid and lipoprotein profiles. A meta-analysis that combined the results of 11 clinical trials found that increasing the consumption of dry beans resulted in modest (6-7%) decreases in total cholesterol and LDL-cholesterol (20). Several characteristics of beans may contribute to their cardioprotective effects. Beans are rich in soluble fiber, which is known to have a cholesterol-lowering effect. Elevated plasma homocysteine levels are associated with increased cardiovascular disease risk, and beans are good sources of folate, which helps to lower homocysteine levels. Beans are also good sources of magnesium and potassium, which may decrease cardiovascular disease risk by helping to lower blood pressure (20). The low-glycemic index values of beans means that they are less likely to raise blood glucose and insulin levels, which may also decrease cardiovascular disease risk. For more information on glycemic index values, see the article on Glycemic Index and Glycemic Load.


In 1999, the US Food and Drug Administration (FDA) approved the following health claim: “Diets low in saturated fat and cholesterol that include 25 grams of soy protein a day may reduce the risk of heart disease” (21). Most of the evidence to support this health claim was included in the Anderson et al. meta-analysis of 38 controlled clinical trials that was published in 1995. This meta-analysis found that an average intake of 47 g/day of soy protein decreased serum total cholesterol levels by an average of 9% and LDL cholesterol levels by an average of 13% (22). Hypocholesterolemic effects were primarily noted in individuals with high baseline cholesterol levels (22). A more recent meta-analysis of 33 studies published since 1995 confirmed the hypocholesterolemic effect of soy protein reported in the Anderson et al. publication (23). Another recent meta-analysis of 30 studies in individuals with normal or mildly elevated cholesterol levels concluded that about 25 g/day of soy protein significantly lowers LDL cholesterol concentrations by about 6% (24). Yet, a recent science advisory from the Nutrition Committee of the American Heart Association concluded that earlier research indicating soy protein consumption results in clinically important reductions in LDL cholesterol compared to other proteins has not been confirmed (25). The consumption of isolated soy isoflavones (as supplements or extracts) does not appear to have favorable effects on serum lipid profiles (26-29). In addition to possibly lowering cholesterol, many soy products may be beneficial for overall cardiovascular health due to their relatively high content of polyunsaturated fat, fiber, and phytosterols compared to animal products (30).


Beans, peas, and lentils

Although beans are rich in a number of compounds that could potentially reduce the risk of certain cancers, the results of epidemiological studies are too inconsistent to draw any firm conclusions regarding bean intake and cancer risk in general (31, 32).

Prostate cancer: There is limited evidence from observational studies that legume intake is inversely related to the risk of prostate cancer. In a six-year prospective study of more than 14,000 Seventh Day Adventist men living in the United States, those with the highest intakes of legumes (beans, lentils, or split peas) had a significantly lower risk of prostate cancer (33). More recently, a prospective study of more than 58,000 men in the Netherlands found that those with the highest intakes of legumes had a risk of prostate cancer that was 29% lower than those with the lowest intakes (34). Similarly, in a case-control study of 1,619 North American men diagnosed with prostate cancer and 1,618 healthy men matched for age and ethnicity, those with the highest legume intakes had a risk of prostate cancer that was 38% lower than those with the lowest intakes (35). Excluding the intake of soy foods from the analysis did not weaken the inverse association between legume intake and prostate cancer, suggesting that soy was not the only legume that conferred protection against prostate cancer. A recent prospective study in a multi-ethnic cohort of 82,483 men examined the risk of prostate cancer in men who consumed legumes excluding soy products. In this study, men who consumed the highest amount of non-soy legumes had a 10% lower risk of total prostate cancer and a 28% lower risk of nonlocalized or high-grade prostate cancer compared to those who consumed the least amount of non-soy legumes (36).


Prostate cancer: Although there is considerable scientific interest in the potential for soy products to prevent prostate cancer, evidence that higher intakes of soy foods can reduce the risk of prostate cancer in humans is limited. Only two out of six case-control studies found that higher intakes of soy products were associated with a significantly lower risk of prostate cancer. In the largest case-control study, North American men who consumed an average of at least 1.4 oz of soy foods daily were 38% less likely to have prostate cancer than men who did not consume soy foods (35). A much smaller case-control study of Chinese men found that men who consumed at least 4 oz of soy foods daily were only half as likely to have prostate cancer as those who consumed less than 1 oz daily (37). However, case-control studies conducted among North American (38, 39), Japanese (40), and Taiwanese men (41) did not find that higher soy intakes were associated with significantly lower prostate cancer risk. A six-year prospective cohort study of more than 12,000 Seventh Day Adventist men in the US found that those who drank soy milk more than once daily had a risk of prostate cancer that was 70% lower than those who never drank soy milk (42), but a 23-year study of more than 5,000 Japanese American men found no association between tofu consumption and prostate cancer risk (43). More recently, a prospective study in a cohort of 43,509 Japanese men found that consumption of soy foods was associated with a decreased risk of localized prostate cancer in men older than 60 years (44). Clinical trials are needed to determine whether consumption of soy foods affects risk of prostate cancer.

Breast cancer: More than 25 epidemiological studies have assessed the relationship between soy food intake and the risk of breast cancer. A recent meta-analysis of prospective cohort studies and case-control studies reported differential effects based on the typical level of soy consumption (45). In Asian populations, where soy intake is high, the authors found an inverse association between soy food intake and breast cancer; however, no association was observed in studies completed in Western populations, where soy food intake is much lower (45). Age at exposure to soy foods may affect subsequent risk of developing breast cancer. For instance, two case-control studies have found higher soy intake during adolescence may lower risk of developing breast cancer later in life (46, 47). Soy intake later in life may not have as strong as an effect on breast cancer as exposure during adolescence (45).

Intake Recommendations

Substituting beans, peas, and lentils for foods that are high in saturated fat or refined carbohydrates is likely to help lower the risk of type 2 DM and cardiovascular disease. Soybeans and foods made from soybeans (soy foods) are excellent sources of protein. In fact, soy protein is complete protein, meaning it provides all of the essential amino acids in adequate amounts for human health (2). Like beans, peas, and lentils, soy foods are also excellent substitutes for protein sources that are high in saturated fat like red meat or cheese. Although a number of health-related organizations recommend daily consumption of five to nine servings (2½-4½ cups) of fruit and vegetables daily (see the article on  Fruit and Vegetables), few make specific recommendations for legumes. In the 2005 Dietary Guidelines for Americans, an intake of 3 cups (6 servings) of legumes weekly is recommended for people who consume about 2,000 kcal/day. A serving of legumes is equal to ½ cup of cooked beans, peas, lentils, or tofu (48). Table 1 lists some potentially beneficial compounds in legumes.

Table 1. Some Potentially Beneficial Compounds in Legumes
Macronutrients Vitamins Minerals Phytochemicals
Essential Fatty Acids Folate Magnesium Fiber
    Potassium Flavonoids
      Soy Isoflavones

Authors and Reviewers

Originally written in 2004 by:
Jane Higdon, Ph.D.
Linus Pauling Institute
Oregon State University

Updated in December 2005 by:
Jane Higdon, Ph.D.
Linus Pauling Institute
Oregon State University

Updated in April 2009 by:
Victoria J. Drake, Ph.D.
Linus Pauling Institute
Oregon State University

Reviewed in April 2009 by:
James W. Anderson, M.D.
Professor of Medicine and Clinical Nutrition
University of Kentucky School of Medicine

Copyright 2004-2019  Linus Pauling Institute


1.  Anderson JW, Smith BM, Washnock CS. Cardiovascular and renal benefits of dry bean and soybean intake. Am J Clin Nutr. 1999;70(3 Suppl):464S-474S.  (PubMed)

2.  Messina MJ. Legumes and soybeans: overview of their nutritional profiles and health effects. Am J Clin Nutr. 1999;70(3 Suppl):439S-450S.  (PubMed)

3.  Willett W, Manson J, Liu S. Glycemic index, glycemic load, and risk of type 2 diabetes. Am J Clin Nutr. 2002;76(1):274S-280S.  (PubMed)

4.  Salmeron J, Ascherio A, Rimm EB, et al. Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care. 1997;20(4):545-550.  (PubMed)

5.  Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC. Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA. 1997;277(6):472-477.  (PubMed)

6.  Patel AV, McCullough ML, Pavluck AL, Jacobs EJ, Thun MJ, Calle EE. Glycemic load, glycemic index, and carbohydrate intake in relation to pancreatic cancer risk in a large US cohort. Cancer Causes Control. 2007;18(3):287-294.  (PubMed)

7.  Krishnan S, Rosenberg L, Singer M, et al. Glycemic index, glycemic load, and cereal fiber intake and risk of type 2 diabetes in US black women. Arch Intern Med. 2007;167(21):2304-2309.  (PubMed)

8.  Ludwig DS. Dietary glycemic index and the regulation of body weight. Lipids. 2003;38(2):117-121.  (PubMed)

9.  Bornet FR, Jardy-Gennetier AE, Jacquet N, Stowell J. Glycaemic response to foods: impact on satiety and long-term weight regulation. Appetite. 2007;49(3):535-553.  (PubMed)

10.  Bouche C, Rizkalla SW, Luo J, et al. Five-week, low-glycemic index diet decreases total fat mass and improves plasma lipid profile in moderately overweight nondiabetic men. Diabetes Care. 2002;25(5):822-828.  (PubMed)

11.  Spieth LE, Harnish JD, Lenders CM, et al. A low-glycemic index diet in the treatment of pediatric obesity. Arch Pediatr Adolesc Med. 2000;154(9):947-951.  (PubMed)

12.  Slabber M, Barnard HC, Kuyl JM, Dannhauser A, Schall R. Effects of a low-insulin-response, energy-restricted diet on weight loss and plasma insulin concentrations in hyperinsulinemic obese females. Am J Clin Nutr. 1994;60(1):48-53.  (PubMed)

13.  Thomas DE, Elliott EJ, Baur L. Low glycaemic index or low glycaemic load diets for overweight and obesity. Cochrane Database Syst Rev. 2007;(3):CD005105.  (PubMed)

14.  Feskens EJ, Bowles CH, Kromhout D. Carbohydrate intake and body mass index in relation to the risk of glucose intolerance in an elderly population. Am J Clin Nutr. 1991;54(1):136-140.  (PubMed)

15.  Villegas R, Gao YT, Yang G, et al. Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health Study. Am J Clin Nutr. 2008;87(1):162-167.  (PubMed)

16.  Nothlings U, Schulze MB, Weikert C, et al. Intake of vegetables, legumes, and fruit, and risk for all-cause, cardiovascular, and cancer mortality in a European diabetic population. J Nutr. 2008;138(4):775-781.  (PubMed)

17.  Bazzano LA, He J, Ogden LG, et al. Legume consumption and risk of coronary heart disease in US men and women: NHANES I Epidemiologic Follow-up Study. Arch Intern Med. 2001;161(21):2573-2578.  (PubMed)

18.  Hu FB, Rimm EB, Stampfer MJ, Ascherio A, Spiegelman D, Willett WC. Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr. 2000;72(4):912-921.  (PubMed)

19.  Fung TT, Willett WC, Stampfer MJ, Manson JE, Hu FB. Dietary patterns and the risk of coronary heart disease in women. Arch Intern Med. 2001;161(15):1857-1862.  (PubMed)

20.  Anderson JW, Major AW. Pulses and lipaemia, short- and long-term effect: potential in the prevention of cardiovascular disease. Br J Nutr. 2002;88 Suppl 3:S263-271.  (PubMed)

21.  US Food and Drug Administration. Final Rule: Food Labeling: Health Claims; Soy Protein and Coronary Heart Disease [Website]. October 26, 1999.

22.  Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med. 1995;333(5):276-282.  (PubMed)

23.  Sirtori CR, Eberini I, Arnoldi A. Hypocholesterolaemic effects of soya proteins: results of recent studies are predictable from the anderson meta-analysis data. Br J Nutr. 2007;97(5):816-822.  (PubMed)

24.  Harland JI, Haffner TA. Systematic review, meta-analysis and regression of randomised controlled trials reporting an association between an intake of circa 25 g soya protein per day and blood cholesterol. Atherosclerosis. 2008;200(1):13-27.  (PubMed)

25.  Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M. Soy Protein, Isoflavones, and Cardiovascular Health. An American Heart Association Science Advisory for Professionals From the Nutrition Committee. Circulation. 2006;113(7):1034-1044.  (PubMed)

26.  Lichtenstein AH, Jalbert SM, Adlercreutz H, et al. Lipoprotein response to diets high in soy or animal protein with and without isoflavones in moderately hypercholesterolemic subjects. Arterioscler Thromb Vasc Biol. 2002;22(11):1852-1858.  (PubMed)

27.  Nikander E, Tiitinen A, Laitinen K, Tikkanen M, Ylikorkala O. Effects of isolated isoflavonoids on lipids, lipoproteins, insulin sensitivity, and ghrelin in postmenopausal women. J Clin Endocrinol Metab. 2004;89(7):3567-3572.  (PubMed)

28.  Weggemans RM, Trautwein EA. Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis. Eur J Clin Nutr. 2003;57(8):940-946.  (PubMed)

29.  Dewell A, Hollenbeck PL, Hollenbeck CB. Clinical review: a critical evaluation of the role of soy protein and isoflavone supplementation in the control of plasma cholesterol concentrations. J Clin Endocrinol Metab. 2006;91(3):772-780.  (PubMed)

30.  Kendall CW, Jenkins DJ. A dietary portfolio: maximal reduction of low-density lipoprotein cholesterol with diet. Curr Atheroscler Rep. 2004;6(6):492-498.  (PubMed)

31.  Mathers JC. Pulses and carcinogenesis: potential for the prevention of colon, breast and other cancers. Br J Nutr. 2002;88 Suppl 3:S273-279.  (PubMed)

32.  World Cancer Research Fund. Food, Nutrition, and the Prevention of Cancer: a global perspective. Washington, D.C.: American Institute for Cancer Research; 1997.

33.  Mills PK, Beeson WL, Phillips RL, Fraser GE. Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer. 1989;64(3):598-604.  (PubMed)

34.  Schuurman AG, Goldbohm RA, Dorant E, van den Brandt PA. Vegetable and fruit consumption and prostate cancer risk: a cohort study in The Netherlands. Cancer Epidemiol Biomarkers Prev. 1998;7(8):673-680.  (PubMed)

35.  Kolonel LN, Hankin JH, Whittemore AS, et al. Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol Biomarkers Prev. 2000;9(8):795-804.  (PubMed)

36.  Park SY, Murphy SP, Wilkens LR, Henderson BE, Kolonel LN. Legume and isoflavone intake and prostate cancer risk: The Multiethnic Cohort Study. Int J Cancer. 2008;123(4):927-932.  (PubMed)

37.  Lee MM, Gomez SL, Chang JS, Wey M, Wang RT, Hsing AW. Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiol Biomarkers Prev. 2003;12(7):665-668.  (PubMed)

38.  Strom SS, Yamamura Y, Duphorne CM, et al. Phytoestrogen intake and prostate cancer: a case-control study using a new database. Nutr Cancer. 1999;33(1):20-25.  (PubMed)

39.  Villeneuve PJ, Johnson KC, Kreiger N, Mao Y. Risk factors for prostate cancer: results from the Canadian National Enhanced Cancer Surveillance System. The Canadian Cancer Registries Epidemiology Research Group. Cancer Causes Control. 1999;10(5):355-367.  (PubMed)

40.  Oishi K, Okada K, Yoshida O, et al. A case-control study of prostatic cancer with reference to dietary habits. Prostate. 1988;12(2):179-190.  (PubMed)

41.  Sung JF, Lin RS, Pu YS, Chen YC, Chang HC, Lai MK. Risk factors for prostate carcinoma in Taiwan: a case-control study in a Chinese population. Cancer. 1999;86(3):484-491.  (PubMed)

42.  Jacobsen BK, Knutsen SF, Fraser GE. Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States). Cancer Causes Control. 1998;9(6):553-557.  (PubMed)

43.  Nomura AM, Hankin JH, Lee J, Stemmermann GN. Cohort study of tofu intake and prostate cancer: no apparent association. Cancer Epidemiol Biomarkers Prev. 2004;13(12):2277-2279.  (PubMed)

44.  Kurahashi N, Iwasaki M, Sasazuki S, Otani T, Inoue M, Tsugane S. Soy product and isoflavone consumption in relation to prostate cancer in Japanese men. Cancer Epidemiol Biomarkers Prev. 2007;16(3):538-545.  (PubMed)

45.  Wu AH, Yu MC, Tseng CC, Pike MC. Epidemiology of soy exposures and breast cancer risk. Br J Cancer. 2008;98(1):9-14.  (PubMed)

46.  Shu XO, Jin F, Dai Q, et al. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev. 2001;10(5):483-488.  (PubMed)

47.  Wu AH, Wan P, Hankin J, Tseng CC, Yu MC, Pike MC. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis. 2002;23(9):1491-1496.  (PubMed)

48.  US Department of Health and Human Services, US Department of Agriculture. Dietary Guidelines for Americans. 2005. Available at: